New Deal
Jeffrey Bluestone
CEO at PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
Manager
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Sonoma Biotherapeutics
Casdin Capital
£190m
15 dealmakers
Senti Biosciences
Dynamics Special Purpose Corporation
£453m
42 dealmakers
Arsenal Biosciences
San Francisco Foundation Investment Company
£191m
14 dealmakers